Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Bayer Inc. Stories

2014-04-17 08:22:44

Inspirational video is launched on World Hemophilia Day to tell the story of one Canadian's triumph over adversity TORONTO, April 17, 2014 /CNW/ - Attitude makes you a hero; that's why John Schmitke, Vice President and Chairman of the Youth Committee at the Canadian Hemophilia Society, Manitoba Chapter, is working to empower and inspire those with hemophilia by sharing his own positive approach to living with this blood disorder. On World Hemophilia Day (April 17, 2014), John...

2014-03-10 08:22:19

-- Bayer's Adempas (riociguat tablets) approved for the treatment of pulmonary arterial hypertension (PAH)(1), which affects up to 2000 Canadians(2) -- Adempas provides novel and specific approach to treat different types of pulmonary hypertension (PH), a serious condition of the heart and lungs -- Only drug in Canada indicated to treat two rare types of PH - PAH and chronic thromboembolic pulmonary hypertension (CTEPH)(1,3) TORONTO, March...

2014-02-05 08:23:11

Survey found that worrying about a birth control fail negatively impacts quality of sex TORONTO, Feb. 5, 2014 /CNW/ - Ahead of Valentine's Day, Bayer Inc. commissioned a national survey testing Canadians' IQs about their sexual health and their knowledge of all things contraception. While 33 per cent of Canadians surveyed anticipate having sex on February 14, 43 per cent who use birth control worry about their contraception failing. Thirty-nine per cent of Canadians surveyed...

2013-10-17 08:22:50

Stivarga(®) (regorafenib tablets) receives expanded approval to include Gastrointestinal Stromal Tumours (GIST) after being approved for metastatic colorectal cancer earlier this year TORONTO, Oct. 17, 2013 /CNW/ - Bayer Inc. announced today Health Canada's expanded approval of Stivarga(®) (regorafenib tablets) to now include treatment of adult patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) who have had disease progression on or intolerance...

2013-09-23 08:22:41

-- Adempas® (riociguat) offers new hope for patients suffering from chronic thromboembolic pulmonary hypertension (CTEPH) -- Adempas® is now available in Canada as the first and only drug indicated to manage the treatment of chronic thromboembolic pulmonary hypertension (CTEPH)1,2 TORONTO, Sept. 23, 2013 /CNW/ - Bayer Inc. announced today the Health Canada approval of Adempas® (riociguat). Adempas® is the first drug...

2013-07-18 08:23:31

-- Significant overall survival benefit observed with radium 223 in patients who received prior treatment with docetaxel and in those who did not -- Radium 223 significantly delayed time to first symptomatic skeletal event -- All main secondary efficacy endpoints with radium 223 were met, showing clinical benefit with radium 223 in patients with castration-resistant prostate cancer and symptomatic...

2013-05-07 08:30:05

Bayer celebrates 150-year anniversary by honouring Canadians who have made a mark on society through science and innovation TORONTO, May 7, 2013 /CNW/ - Scientists and innovators have guided every step in Bayer's 150-year journey to becoming a global leader in healthcare, crop and material sciences. As it marks its 150(th) anniversary this year, Bayer also celebrates Canadian innovation and individuals who exemplify the curiosity and commitment to help shape a better future. Bayer is...

2013-03-25 08:21:39

Stivarga(®) (Regorafenib tablets) demonstrated extended overall survival in patients with Metastatic Colorectal Cancer whose disease progressed after previous treatments TORONTO, March 25, 2013 /CNW/ - Bayer Inc. announced today the Health Canada approval of Stivarga (regorafenib tablets), indicated for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-based chemotherapy, oxaliplatin, irinotecan, an...

2013-01-09 08:22:17

New CONTOUR(®) NEXT EZ Strip and Meter Combination is accurate and easy to use TORONTO, Jan. 9, 2013 /CNW/ - A new, accurate and easy-to-use blood glucose monitoring system is now available for diabetes patients in Canada. The CONTOUR(®) NEXT EZ meter combines easy-to-use features and next-generation accuracy with Bayer's new CONTOUR(®) NEXT test strip to help patients better manage their diabetes. "Bayer's new CONTOUR(®) NEXT EZ system is especially accurate in low...

2012-12-04 05:02:11

Former fighter pilot, Jim "Murph" Murphy, delivered his nationally acclaimed Flawless Execution® model to more than 60 members of Bayer Healthcare Pharmaceuticals leadership team in Lisbon, Portugal Atlanta, GA (PRWEB) December 03, 2012 Jim Murphy, founder of the global management training firm, Afterburner, was featured as the guest speaker at Bayer Healthcare´s annual leadership meeting in Portugal this month. The concept behind Flawless Execution® combines combat-derived...